4,4'-[六氢呋喃并[3,4-c]呋喃-1,4-二基]双(2-甲氧基苯酚) | 7452-03-1

• 物质功能分类: 有机原料 - 醇、酚、酚醇类化合物及衍生物 - 酚醇类极其卤化、磺化、硝化或亚硝化衍生物
• 分子结构分类: 有机化合物 - 木脂素、新木脂素和相关化合物 - 呋喃类木脂素
• 中文名称: 4,4'-[六氢呋喃并[3,4-c]呋喃-1,4-二基]双(2-甲氧基苯酚)
• 中文别名: 4,4'-[六氢呋喃并[3,4-C]呋喃-1,4-二基]双(2-甲氧基苯酚)
• 英文名称: pinoresinol
• 英文别名: (±)-pinoresinol；2,2'-dimethoxy-4,4'-(tetrahydro-furo[3,4-c]furan-1,4-diyl)-bis-phenol；1,4-Bis-(4-hydroxy-3-methoxy-phenyl)-tetrahydro-furo[3,4-c]furan；2,6-bis-(3-methoxy-4-hydroxy phenyl)-cis-3,7-dioxabicyclo[3.3.0]octane；2,6-bis-(3-methoxy-4-hydroxyphenyl)-3,7-dioxabicyclo[3.3.0]octane；4-[6-(4-Hydroxy-3-methoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenol
• CAS: 7452-03-1
• 化学式: C₂₀H₂₂O₆
• 分子量: 358.391
• InChiKey: HGXBRUKMWQGOIE-UHFFFAOYSA-N

物化性质

• 熔点：
  120 °C
• 沸点：
  556.5±50.0 °C(Predicted)
• 密度：
  1.287±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  26
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  77.4
• 氢给体数：
  2
• 氢受体数：
  6

安全信息

• 储存条件：
  温度低于0°C时，请避免加热。

制备方法与用途

自组装材料与接触印刷材料

反应信息

• 作为反应物：
  描述：

  4,4'-[六氢呋喃并[3,4-c]呋喃-1,4-二基]双(2-甲氧基苯酚) 在 2,3-二氯-5,6-二氰基-1,4-苯醌 作用下， 以 甲醇 为溶剂， 反应 1.0h， 以39%的产率得到2,6-bis(4'-hydroxy-3'-methoxyphenyl)-3,7-dioxabicyclo<3.3.0>octa-1,5-diene
  参考文献：
  名称：

  Jack, Ibiba R.; Ward, R. S.; Pelter, A., Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1989, vol. 28, # 1-11, p. 184 - 185

  摘要：

  DOI：
• 作为产物：
  描述：

  香草乙酮 在 carrageenan gel 、 双氧水 、 horseradish peroxidase 作用下， 以 phosphate buffer 、 丙酮 为溶剂， 反应 20.0h， 生成 4,4'-[六氢呋喃并[3,4-c]呋喃-1,4-二基]双(2-甲氧基苯酚)
  参考文献：
  名称：

  Regioselectivity in oxidative cross-coupling of phenols. Application to the synthesis of dimeric neolignans

  摘要：

  The problems of regioselectivity in oxidative coupling of phenols are outlined, and recent research on the application to the synthesis of lignans and neolignans is reviewed. Lignans and neolignans are dimers that are typically formed by oxidative coupling of propenyl phenols. The coupling of structurally different phenols (cross-coupling) is an extension of this synthesis. Recent results show that cross-coupling can be achieved if the phenols have compatible reactivities. The regioselectivity is often quite different in cross-coupling compared to dimerization. Coupling of phenols with widely different rates of oxidation is difficult but can be achieved if the concentration of the more reactive phenol can be kept low enough during the reaction, for instance by diffusion through a dialysis membrane. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(00)00943-1

文献信息

• Sulfur(VI) fluoride compounds and methods for the preparation thereof
  申请人：The Scripps Research Institute

  公开号：US10117840B2

  公开（公告）日：2018-11-06

  This application describes a compound represented by Formula (I): (I) wherein: Y is a biologically active organic core group comprising one or more of an aryl group, a heteroaryl aryl group, a nonaromatic hydrocarbyl group, and a nonaromatic heterocyclic group, to which Z is covalently bonded; n is 1, 2, 3, 4 or 5; m is 1 or 2; Z is O, NR, or N; X1 is a covalent bond or —CH2CH2—, X2 is O or NR; and R comprises H or a substituted or unsubstituted group selected from an aryl group, a heteroaryl aryl group, a nonaromatic hydrocarbyl group, and a nonaromatic heterocyclic group. Methods of preparing the compounds, methods of using the compounds, and pharmaceutical compositions comprising the compounds are described as well.

  该应用描述了由式(I)表示的化合物：(I)其中：Y是一个生物活性有机核心基团，包括芳基、杂芳基、非芳香烃基和非芳香杂环基中的一个或多个，其中Z与之以共价键结合；n为1、2、3、4或5；m为1或2；Z为O、NR或N；X1为共价键或—CH2CH2—，X2为O或NR；R包括H或从芳基、杂芳基、非芳香烃基和非芳香杂环基中选择的取代或未取代基团。还描述了制备这些化合物的方法、使用这些化合物的方法以及包含这些化合物的药物组合物。
• Compositions and methods for treating hemorrhagic virus infections and other disorders
  申请人：——

  公开号：US20020077276A1

  公开（公告）日：2002-06-20

  Cytokine-receptor and cytokine antagonist-enriched blood-dervided compositions and methods of preparing and using the compositions are provided. Also provided are compositions and methods for the treatment or prevention of disorders, especially acute inflammatory disorders involving pathological responses of the immune system, such as viral hemorrhagic diseases, sepsis, rheumatoid arthritis and other autoimmune disorders, acute cardiovascular events, flare-ups and acute phases of multiple sclerosis, wasting disorders and other disorders involving deleterious expression of cytokines and other factors, including tumor necrosis factor (TNF) and interleukin-1 (IL-1) are provided.

  提供了富含细胞因子受体和细胞因子拮抗剂的血液衍生物组合物的制备和使用方法。还提供了用于治疗或预防疾病的组合物和方法，特别是涉及免疫系统病理反应的急性炎症性疾病，如病毒性出血热疾病、败血症、类风湿关节炎和其他自身免疫性疾病、急性心血管事件、多发性硬化的急性阶段、消耗性疾病和其他涉及细胞因子和其他因子有害表达的疾病，包括肿瘤坏死因子（TNF）和白细胞介素-1（IL-1）。
• Synthesis and Characterization of New 5-Linked Pinoresinol Lignin Models
  作者：Fengxia Yue、Fachuang Lu、Runcang Sun、John Ralph

  DOI：10.1002/chem.201201506

  日期：2012.12.14

  alcohol producing pinoresinol‐containing trimers (and higher oligomers) in addition to other homo‐ and cross‐coupled products. Eight new lignin model compounds were obtained and characterized by NMR spectroscopy, and one tentatively identified cross‐coupled β‐O‐4′‐product was formed from a coniferyl alcohol 5‐O‐4′‐linked dimer. It was demonstrated that the 5‐5′‐ and 5‐O‐4′‐linked pinoresinol structures could

  松脂醇结构具有木质素单体单元之间的β-β'键，在软木木质素以及双子叶植物和单子叶植物中，特别是在丁香基特异性基因中被下调的那些中，都非常重要。虽然容易通过NMR光谱检测，松脂醇结构主要由β-醚裂解降解逃过检测分析推测由于联系的在5个位置的存在下，在5-5'-或5- ö -4'-结构。在这项研究中，旨在通过提供NMR表征所需的数据来帮助更好地理解5-连接的松脂醇结构，新的木质素模型化合物是通过仿生过氧化物酶介导的预制（游离酚）松柏树醇之间的氧化偶联反应合成的5‐5′‐或5‐ O‐4′-连接的二聚体和松柏醇单体。结果发现，除其他均相和交联产物外，此类含有游离酚类松柏醇部分的二聚体还可与产生松柏醇的三聚松脂（及高级低聚物）的松柏醇交叉偶联。获得和表征通过NMR谱八个新木质素模型化合物，和一种初步确定交叉耦合β -O- 4'-产物从一个松柏醇形成5- ö -4'-连接的二聚体。证明了5‐5′‐和5‐
• Methods for chemical synthesis of biologically active compounds using supramolecular protective groups and novel compounds obtainable Thereby
  申请人：Herrmann Andreas

  公开号：US20140243280A1

  公开（公告）日：2014-08-28

  The invention relates to drug development and synthetic chemistry, in particular to the manufacture of biologically active compounds based on naturally occurring molecules. It also relates to novel biologically active compounds, for example aminoglycoside antibiotics, in a substantially pure regioisomeric form.

  这项发明涉及药物开发和合成化学，特别是基于天然分子制造生物活性化合物。它还涉及新型生物活性化合物，例如氨基糖苷类抗生素，以较纯的位置异构形式存在。
• [EN] BIOACTIVE PHENOLATE IONIC COMPLEXES<br/>[FR] COMPLEXES IONIQUES PHÉNOLATE BIOACTIFS
  申请人：YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD

  公开号：WO2021214762A1

  公开（公告）日：2021-10-28

  The invention provides an isolated material, or a phenolate form of at least one phenol- containing active material, wherein the isolated material comprises one or more phenolate species and a counter ion (a cation) in the form of a metal salt, a phosphonium or an ammonium.

  该发明提供了一种孤立的材料，或者至少一种含酚活性物质的酚酚酚形式，其中该孤立的材料包括一个或多个酚酚酚物种和一个对离子（阳离子）的金属盐、磷酰胺或铵的形式。

表征谱图